We will see, IMO it won’t change anything. Are we to think all the other things we have going wasn’t sufficient to bring us to profitability? RecoveryRx is in a class by itself and should have been focused on striving for Standard of Care, that’s where the money is. We didn’t get a bounce for that huge approval, which makes me think Full Clearance won’t get a bounce either. We are victims of management perception by the Market simple as that. JMHO GLTA